Enlivex Therapeutics Ltd. (ENLV) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.12
Day's range
$1.17

Enlivex Therapeutics Ltd Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
DIAMETRIC CAPITAL, LP 05/15/2026 1.48 M $1.38 M   100.00% 3.25%
ARK INVESTMENT MANAGEMENT LLC 05/12/2026 628.31 K $584.39 K   100.00% 1.38%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2026 225.74 K $209.96 K   100.00% 0.49%
TWO SIGMA INVESTMENTS, LP 05/15/2026 146.41 K $136.18 K   -24.97% 0.32%
UBS GROUP AG 05/05/2026 138.33 K $128.65 K   295.36% 0.30%
BANK OF AMERICA CORP /DE/ 05/18/2026 130.40 K $121.27 K   53.24% 0.29%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 128.19 K $119.23 K   -59.13% 0.28%
JPMORGAN CHASE & CO 05/13/2026 125.95 K $113.35 K   5,835.34% 0.28%
GOLDMAN SACHS GROUP INC 05/15/2026 102.09 K $94.96 K   100.00% 0.22%
XTX TOPCO LTD 05/15/2026 100.36 K $93.35 K   62.40% 0.22%
MORGAN STANLEY 05/15/2026 98.33 K $91.46 K   -50.99% 0.22%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 80.56 K $74.93 K   100.00% 0.18%
INVESCO LTD. 05/12/2026 61.65 K $57.34 K   1.20% 0.13%
VIRTU FINANCIAL LLC 05/14/2026 43.25 K $40.00 K   -8.71% 0.09%
CITADEL ADVISORS LLC 05/15/2026 27.97 K $26.01 K   9.29% 0.06%
CITADEL ADVISORS LLC 05/15/2026 24.10 K $22.42 K   -2.03% 0.05%
TWO SIGMA SECURITIES, LLC 05/15/2026 20.04 K $18.64 K   100.00% 0.04%
PROSPERITY CONSULTING GROUP, LLC 05/05/2026 17.65 K $16.41 K   0.00% 0.04%
HARBOUR INVESTMENTS, INC. 05/15/2026 16.00 K $14.88 K   100.00% 0.04%
MILLENNIUM MANAGEMENT LLC 05/15/2026 11.78 K $10.96 K   100.00% 0.03%
NEUBERGER BERMAN GROUP LLC 05/14/2026 10.99 K $10.22 K   0.00% 0.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 10.31 K $9.59 K   100.00% 0.02%
SKYVIEW INVESTMENT ADVISORS, LLC 05/15/2026 10.00 K $9.00 K   0.00% 0.02%
WELLS FARGO & COMPANY/MN 05/11/2026 9.38 K $8.73 K   2.18% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 2.88 K $2.68 K   28.55% 0.01%
SIMPLEX TRADING, LLC 05/14/2026 2.62 K $2.43 K   -70.55% 0.01%
05/14/2026 2.50 K $2.33 K   0.00% 0.01%
ADVISOR GROUP HOLDINGS, INC. 05/15/2026 1.17 K $1.09 K   -45.23% 0.00%
SRS CAPITAL ADVISORS, INC. 05/13/2026 1.02 K $945   0.00% 0.00%
ACTIVEST WEALTH MANAGEMENT 04/15/2026 1.00 K $930   0.00% 0.00%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 05/08/2026 500 $465   0.00% 0.00%
GROUP ONE TRADING, L.P. 05/13/2026 207 $193   100.00% 0.00%
RED TORTOISE LLC 04/21/2026 150 $140   0.00% 0.00%
TD WATERHOUSE CANADA INC. 05/12/2026 150 $144   100.00% 0.00%
US BANCORP \DE\ 05/15/2026 50 $47   100.00% 0.00%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 05/11/2026 1 $1   100.00% 0.00%
CITADEL ADVISORS LLC 05/15/2026 0 $0   -100.00% 0.00%
HRT FINANCIAL LP 05/14/2026 0 $0   -100.00% 0.00%
JANE STREET GROUP, LLC 05/12/2026 0 $0   -100.00% 0.00%
BFSG, LLC 04/29/2026 0 $0   -100.00% 0.00%

Enlivex Therapeutics Ltd institutional Ownership - FAQ's

During the previous two years, 39 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd. The most heavily invested institutionals were:

Diametric Capital, LP: 1.48 M

ARK Investment Management LLC: 628,310

PRELUDE CAPITAL MANAGEMENT, LLC: 225,738

TWO SIGMA INVESTMENTS, LP: 146,412

UBS Group AG: 138,328

BANK OF AMERICA CORP /DE/: 130,401

8.01% of Enlivex Therapeutics Ltd stock is owned by institutional investors.

Institutional investors have bought a total of 3.64 M shares in the last 24 months. This purchase volume represents approximately $4.22 M in transactions.